

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.17007219 |
| 2 | ribosomal small subunit biogenesis (GO:0042274) | 4.89251619 |
| 3 | maturation of SSU-rRNA (GO:0030490) | 4.88383330 |
| 4 | viral transcription (GO:0019083) | 4.84286088 |
| 5 | DNA deamination (GO:0045006) | 4.80012141 |
| 6 | translational termination (GO:0006415) | 4.75272927 |
| 7 | proteasome assembly (GO:0043248) | 4.61755101 |
| 8 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.61468798 |
| 9 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.51360381 |
| 10 | DNA strand elongation (GO:0022616) | 4.39195178 |
| 11 | ribosomal large subunit biogenesis (GO:0042273) | 4.38711746 |
| 12 | DNA replication initiation (GO:0006270) | 4.31371874 |
| 13 | formation of translation preinitiation complex (GO:0001731) | 4.27931759 |
| 14 | translational elongation (GO:0006414) | 4.25827001 |
| 15 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.20237408 |
| 16 | translational initiation (GO:0006413) | 4.15655912 |
| 17 | cotranslational protein targeting to membrane (GO:0006613) | 4.14311141 |
| 18 | CENP-A containing nucleosome assembly (GO:0034080) | 4.13752163 |
| 19 | DNA replication checkpoint (GO:0000076) | 4.11624410 |
| 20 | protein targeting to ER (GO:0045047) | 4.10200332 |
| 21 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.10100201 |
| 22 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.09351425 |
| 23 | protein localization to chromosome, centromeric region (GO:0071459) | 4.07199721 |
| 24 | nuclear pore complex assembly (GO:0051292) | 4.06726048 |
| 25 | mitotic chromosome condensation (GO:0007076) | 4.03700810 |
| 26 | telomere maintenance via recombination (GO:0000722) | 4.03608019 |
| 27 | chromatin remodeling at centromere (GO:0031055) | 3.97364070 |
| 28 | nucleobase biosynthetic process (GO:0046112) | 3.97027525 |
| 29 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.94682933 |
| 30 | mitotic metaphase plate congression (GO:0007080) | 3.94640057 |
| 31 | termination of RNA polymerase III transcription (GO:0006386) | 3.93944047 |
| 32 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.93944047 |
| 33 | purine nucleobase biosynthetic process (GO:0009113) | 3.93456657 |
| 34 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.91426883 |
| 35 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.90660334 |
| 36 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.88824291 |
| 37 | spliceosomal snRNP assembly (GO:0000387) | 3.88474045 |
| 38 | protein localization to endoplasmic reticulum (GO:0070972) | 3.87792091 |
| 39 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.86489059 |
| 40 | establishment of viral latency (GO:0019043) | 3.84343552 |
| 41 | cellular protein complex disassembly (GO:0043624) | 3.78132185 |
| 42 | negative regulation of ligase activity (GO:0051352) | 3.76987734 |
| 43 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.76987734 |
| 44 | viral life cycle (GO:0019058) | 3.76526389 |
| 45 | 7-methylguanosine mRNA capping (GO:0006370) | 3.75396208 |
| 46 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.74613164 |
| 47 | mitotic recombination (GO:0006312) | 3.73787348 |
| 48 | rRNA processing (GO:0006364) | 3.73582642 |
| 49 | ribosome biogenesis (GO:0042254) | 3.73506528 |
| 50 | rRNA modification (GO:0000154) | 3.72074716 |
| 51 | ribosome assembly (GO:0042255) | 3.71503579 |
| 52 | translation (GO:0006412) | 3.69577522 |
| 53 | RNA capping (GO:0036260) | 3.68830084 |
| 54 | 7-methylguanosine RNA capping (GO:0009452) | 3.68830084 |
| 55 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.65683505 |
| 56 | kinetochore assembly (GO:0051382) | 3.63947523 |
| 57 | kinetochore organization (GO:0051383) | 3.63613329 |
| 58 | nuclear pore organization (GO:0006999) | 3.62336186 |
| 59 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.61486537 |
| 60 | DNA replication-independent nucleosome organization (GO:0034724) | 3.61486537 |
| 61 | telomere maintenance via telomere lengthening (GO:0010833) | 3.59860938 |
| 62 | rRNA metabolic process (GO:0016072) | 3.58274767 |
| 63 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.58132285 |
| 64 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.57272175 |
| 65 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.55366204 |
| 66 | spliceosomal complex assembly (GO:0000245) | 3.54159819 |
| 67 | mitotic sister chromatid segregation (GO:0000070) | 3.53617267 |
| 68 | IMP biosynthetic process (GO:0006188) | 3.52959495 |
| 69 | protein complex localization (GO:0031503) | 3.52843739 |
| 70 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.51927984 |
| 71 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.49079376 |
| 72 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.49079376 |
| 73 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.48007675 |
| 74 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.48007675 |
| 75 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.48007675 |
| 76 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.46729317 |
| 77 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.46524030 |
| 78 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.45300861 |
| 79 | protein localization to kinetochore (GO:0034501) | 3.42874593 |
| 80 | heterochromatin organization (GO:0070828) | 3.42530126 |
| 81 | establishment of integrated proviral latency (GO:0075713) | 3.41693644 |
| 82 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.41671044 |
| 83 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.41671044 |
| 84 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.40870067 |
| 85 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.40417241 |
| 86 | DNA unwinding involved in DNA replication (GO:0006268) | 3.38909428 |
| 87 | pseudouridine synthesis (GO:0001522) | 3.38483448 |
| 88 | cellular component biogenesis (GO:0044085) | 3.37891870 |
| 89 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.37559222 |
| 90 | mitotic nuclear envelope disassembly (GO:0007077) | 3.35492334 |
| 91 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.34447456 |
| 92 | protein complex disassembly (GO:0043241) | 3.34169591 |
| 93 | metaphase plate congression (GO:0051310) | 3.32631251 |
| 94 | cell cycle G1/S phase transition (GO:0044843) | 3.32156631 |
| 95 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.32156631 |
| 96 | regulation of mitochondrial translation (GO:0070129) | 3.32077767 |
| 97 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.31064209 |
| 98 | histone exchange (GO:0043486) | 3.29826405 |
| 99 | cellular protein complex localization (GO:0034629) | 3.29403863 |
| 100 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.29042429 |
| 101 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.29042429 |
| 102 | positive regulation of ligase activity (GO:0051351) | 3.26572628 |
| 103 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.26282726 |
| 104 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.25999871 |
| 105 | regulation of translational fidelity (GO:0006450) | 3.23980007 |
| 106 | termination of RNA polymerase I transcription (GO:0006363) | 3.23642152 |
| 107 | viral mRNA export from host cell nucleus (GO:0046784) | 3.23552615 |
| 108 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.21837224 |
| 109 | ATP synthesis coupled proton transport (GO:0015986) | 3.21837224 |
| 110 | cullin deneddylation (GO:0010388) | 3.20982646 |
| 111 | protein deneddylation (GO:0000338) | 3.19251669 |
| 112 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.19176744 |
| 113 | macromolecular complex disassembly (GO:0032984) | 3.18757813 |
| 114 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.18663834 |
| 115 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.18375704 |
| 116 | transcription from RNA polymerase I promoter (GO:0006360) | 3.17050458 |
| 117 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.15695202 |
| 118 | histone arginine methylation (GO:0034969) | 3.15316071 |
| 119 | IMP metabolic process (GO:0046040) | 3.14908075 |
| 120 | sister chromatid segregation (GO:0000819) | 3.11839567 |
| 121 | nuclear envelope disassembly (GO:0051081) | 3.11410514 |
| 122 | membrane disassembly (GO:0030397) | 3.11410514 |
| 123 | establishment of chromosome localization (GO:0051303) | 3.07096688 |
| 124 | L-serine metabolic process (GO:0006563) | 3.04794229 |
| 125 | regulation of translational termination (GO:0006449) | 3.03269726 |
| 126 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.00903265 |
| 127 | non-recombinational repair (GO:0000726) | 3.00903265 |
| 128 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.00764569 |
| 129 | pore complex assembly (GO:0046931) | 3.00064726 |
| 130 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.98538914 |
| 131 | positive regulation of chromosome segregation (GO:0051984) | 2.95783653 |
| 132 | chromatin assembly or disassembly (GO:0006333) | 2.95022072 |
| 133 | protein targeting to mitochondrion (GO:0006626) | 2.90332582 |
| 134 | DNA ligation (GO:0006266) | 2.90044771 |
| 135 | regulation of chromosome segregation (GO:0051983) | 2.89646038 |
| 136 | negative regulation of chromosome segregation (GO:0051985) | 2.88519705 |
| 137 | rRNA transcription (GO:0009303) | 2.88278089 |
| 138 | maturation of 5.8S rRNA (GO:0000460) | 2.87861759 |
| 139 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.87367024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.87450979 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.55669354 |
| 3 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.19759473 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.85151299 |
| 5 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.82219528 |
| 6 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.79614147 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.58318550 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.43182914 |
| 9 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.36039189 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.27120411 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.14126152 |
| 12 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.12947411 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.06226353 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.01341115 |
| 15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.99887535 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.99019190 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.91499643 |
| 18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.82775096 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.79137926 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.56199806 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.55906316 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.53736509 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.50394540 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.49575106 |
| 25 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.41476772 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37849059 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.32096572 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.27624331 |
| 29 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.15003416 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.07315021 |
| 31 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.06919359 |
| 32 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.05967030 |
| 33 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.97583613 |
| 34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.93983196 |
| 35 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.91947788 |
| 36 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.91446476 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.91012421 |
| 38 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.84462009 |
| 39 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.84025063 |
| 40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82278775 |
| 41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.79200036 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.77811823 |
| 43 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76967312 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75758181 |
| 45 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.65986099 |
| 46 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.63239352 |
| 47 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.63030276 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60490779 |
| 49 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.56889178 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51345201 |
| 51 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.46650066 |
| 52 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45623875 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.44324230 |
| 54 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40667875 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39653679 |
| 56 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.34374355 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34346322 |
| 58 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30297464 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28682806 |
| 60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.27097259 |
| 61 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26484673 |
| 62 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.24888782 |
| 63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.22543597 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21366504 |
| 65 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20855073 |
| 66 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.18894896 |
| 67 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.18230740 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18213905 |
| 69 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.16911086 |
| 70 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.16821819 |
| 71 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.16301188 |
| 72 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13328823 |
| 73 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13007626 |
| 74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11830211 |
| 75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11231432 |
| 76 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.10652961 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.10289551 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10201951 |
| 79 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09818153 |
| 80 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.07822965 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02699278 |
| 82 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.02643094 |
| 83 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02155198 |
| 84 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01979175 |
| 85 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.01092325 |
| 86 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98992777 |
| 87 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.98188334 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97380692 |
| 89 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95363651 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94439488 |
| 91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93485345 |
| 92 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92077694 |
| 93 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.91130608 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89854836 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87755993 |
| 96 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.86774338 |
| 97 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.86603454 |
| 98 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.86044318 |
| 99 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.84025224 |
| 100 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.82667260 |
| 101 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.82493979 |
| 102 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.82287553 |
| 103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.81960401 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81302097 |
| 105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.79548296 |
| 106 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.79504220 |
| 107 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.77710397 |
| 108 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.76250033 |
| 109 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.76248032 |
| 110 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.76121630 |
| 111 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75814980 |
| 112 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.73173396 |
| 113 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.72676967 |
| 114 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.69193173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 6.24317629 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.65589867 |
| 3 | MP0010094_abnormal_chromosome_stability | 4.46368521 |
| 4 | MP0003111_abnormal_nucleus_morphology | 4.39244136 |
| 5 | MP0003077_abnormal_cell_cycle | 4.06731348 |
| 6 | MP0008057_abnormal_DNA_replication | 3.78331358 |
| 7 | MP0008058_abnormal_DNA_repair | 3.59577990 |
| 8 | MP0008932_abnormal_embryonic_tissue | 3.08376549 |
| 9 | MP0003718_maternal_effect | 2.73656636 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.65172713 |
| 11 | MP0003786_premature_aging | 2.37657762 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.28902221 |
| 13 | MP0003123_paternal_imprinting | 2.22614581 |
| 14 | MP0001730_embryonic_growth_arrest | 2.19521497 |
| 15 | MP0009379_abnormal_foot_pigmentation | 2.11861771 |
| 16 | MP0003186_abnormal_redox_activity | 2.02572135 |
| 17 | MP0000350_abnormal_cell_proliferation | 1.94120277 |
| 18 | MP0003315_abnormal_perineum_morphology | 1.89721086 |
| 19 | MP0002396_abnormal_hematopoietic_system | 1.81857812 |
| 20 | MP0008877_abnormal_DNA_methylation | 1.72955803 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.65682752 |
| 22 | MP0006292_abnormal_olfactory_placode | 1.63116642 |
| 23 | MP0004185_abnormal_adipocyte_glucose | 1.62519392 |
| 24 | MP0004233_abnormal_muscle_weight | 1.61535014 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.56275062 |
| 26 | MP0001697_abnormal_embryo_size | 1.52969479 |
| 27 | MP0004147_increased_porphyrin_level | 1.52216796 |
| 28 | MP0001529_abnormal_vocalization | 1.50490518 |
| 29 | MP0009672_abnormal_birth_weight | 1.47099085 |
| 30 | MP0000490_abnormal_crypts_of | 1.45389582 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.44416523 |
| 32 | MP0000313_abnormal_cell_death | 1.41327534 |
| 33 | MP0001672_abnormal_embryogenesis/_devel | 1.40974100 |
| 34 | MP0005380_embryogenesis_phenotype | 1.40974100 |
| 35 | MP0009697_abnormal_copulation | 1.39779309 |
| 36 | MP0002080_prenatal_lethality | 1.39174649 |
| 37 | MP0002796_impaired_skin_barrier | 1.36525992 |
| 38 | MP0002132_abnormal_respiratory_system | 1.35707712 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.33277061 |
| 40 | MP0001346_abnormal_lacrimal_gland | 1.31653649 |
| 41 | MP0005501_abnormal_skin_physiology | 1.30034436 |
| 42 | MP0003136_yellow_coat_color | 1.28374346 |
| 43 | MP0002085_abnormal_embryonic_tissue | 1.28357897 |
| 44 | MP0002102_abnormal_ear_morphology | 1.24826268 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.23878582 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.23169287 |
| 47 | MP0003984_embryonic_growth_retardation | 1.22480639 |
| 48 | MP0003567_abnormal_fetal_cardiomyocyte | 1.22240033 |
| 49 | MP0005408_hypopigmentation | 1.19472233 |
| 50 | MP0002210_abnormal_sex_determination | 1.19350323 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 1.18909094 |
| 52 | MP0002088_abnormal_embryonic_growth/wei | 1.18051219 |
| 53 | MP0002697_abnormal_eye_size | 1.15968638 |
| 54 | MP0002160_abnormal_reproductive_system | 1.15127798 |
| 55 | MP0001293_anophthalmia | 1.14842589 |
| 56 | MP0002938_white_spotting | 1.11857065 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.09583346 |
| 58 | MP0008260_abnormal_autophagy | 1.07419665 |
| 59 | MP0000372_irregular_coat_pigmentation | 1.06910267 |
| 60 | MP0001661_extended_life_span | 1.04026580 |
| 61 | MP0001145_abnormal_male_reproductive | 1.03147567 |
| 62 | MP0002254_reproductive_system_inflammat | 1.02056651 |
| 63 | MP0008789_abnormal_olfactory_epithelium | 0.99484632 |
| 64 | MP0002084_abnormal_developmental_patter | 0.97827943 |
| 65 | MP0000358_abnormal_cell_content/ | 0.96577127 |
| 66 | MP0004133_heterotaxia | 0.95525608 |
| 67 | MP0003121_genomic_imprinting | 0.94736625 |
| 68 | MP0005389_reproductive_system_phenotype | 0.94138215 |
| 69 | MP0002163_abnormal_gland_morphology | 0.93492412 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.92056446 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 0.91276801 |
| 72 | MP0000653_abnormal_sex_gland | 0.91066161 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 0.90219190 |
| 74 | MP0010307_abnormal_tumor_latency | 0.88611883 |
| 75 | MP0003890_abnormal_embryonic-extraembry | 0.88361353 |
| 76 | MP0001849_ear_inflammation | 0.88323969 |
| 77 | MP0001929_abnormal_gametogenesis | 0.88296549 |
| 78 | MP0002086_abnormal_extraembryonic_tissu | 0.87871387 |
| 79 | MP0003941_abnormal_skin_development | 0.87489598 |
| 80 | MP0002092_abnormal_eye_morphology | 0.84529053 |
| 81 | MP0003937_abnormal_limbs/digits/tail_de | 0.84155897 |
| 82 | MP0001119_abnormal_female_reproductive | 0.83425321 |
| 83 | MP0003763_abnormal_thymus_physiology | 0.83300648 |
| 84 | MP0006054_spinal_hemorrhage | 0.81857534 |
| 85 | MP0002722_abnormal_immune_system | 0.81792869 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81256874 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.80907387 |
| 88 | MP0010352_gastrointestinal_tract_polyps | 0.79715376 |
| 89 | MP0005451_abnormal_body_composition | 0.79591613 |
| 90 | MP0005621_abnormal_cell_physiology | 0.79412008 |
| 91 | MP0002398_abnormal_bone_marrow | 0.79085901 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.78511428 |
| 93 | MP0001545_abnormal_hematopoietic_system | 0.78511428 |
| 94 | MP0000689_abnormal_spleen_morphology | 0.78425858 |
| 95 | MP0004197_abnormal_fetal_growth/weight/ | 0.76357745 |
| 96 | MP0001853_heart_inflammation | 0.75720889 |
| 97 | MP0002095_abnormal_skin_pigmentation | 0.73433695 |
| 98 | MP0001881_abnormal_mammary_gland | 0.73307877 |
| 99 | MP0000678_abnormal_parathyroid_gland | 0.72721789 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.72659406 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.71838322 |
| 102 | MP0000428_abnormal_craniofacial_morphol | 0.71110599 |
| 103 | MP0002653_abnormal_ependyma_morphology | 0.69556155 |
| 104 | MP0009053_abnormal_anal_canal | 0.68625303 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 0.68347515 |
| 106 | MP0001286_abnormal_eye_development | 0.68179562 |
| 107 | MP0001348_abnormal_lacrimal_gland | 0.68061780 |
| 108 | MP0001727_abnormal_embryo_implantation | 0.67848145 |
| 109 | MP0005395_other_phenotype | 0.67555616 |
| 110 | MP0008995_early_reproductive_senescence | 0.67537316 |
| 111 | MP0002429_abnormal_blood_cell | 0.67414656 |
| 112 | MP0005257_abnormal_intraocular_pressure | 0.66952991 |
| 113 | MP0003119_abnormal_digestive_system | 0.66114612 |
| 114 | MP0002111_abnormal_tail_morphology | 0.65860330 |
| 115 | MP0001919_abnormal_reproductive_system | 0.65788481 |
| 116 | MP0000762_abnormal_tongue_morphology | 0.65547270 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.65026268 |
| 118 | MP0009703_decreased_birth_body | 0.64582320 |
| 119 | MP0003699_abnormal_female_reproductive | 0.63835597 |
| 120 | MP0000049_abnormal_middle_ear | 0.63261146 |
| 121 | MP0000566_synostosis | 0.63079781 |
| 122 | MP0003938_abnormal_ear_development | 0.62508126 |
| 123 | MP0005384_cellular_phenotype | 0.62043493 |
| 124 | MP0000750_abnormal_muscle_regeneration | 0.62004953 |
| 125 | MP0001905_abnormal_dopamine_level | 0.61719745 |
| 126 | MP0000858_altered_metastatic_potential | 0.61692610 |
| 127 | MP0001216_abnormal_epidermal_layer | 0.61674418 |
| 128 | MP0000537_abnormal_urethra_morphology | 0.61364317 |
| 129 | MP0005266_abnormal_metabolism | 0.61335232 |
| 130 | MP0001915_intracranial_hemorrhage | 0.56718209 |
| 131 | MP0002233_abnormal_nose_morphology | 0.53259337 |
| 132 | MP0000627_abnormal_mammary_gland | 0.52762206 |
| 133 | MP0000579_abnormal_nail_morphology | 0.52095792 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.50084500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.79463872 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.40137761 |
| 3 | Reticulocytopenia (HP:0001896) | 5.06280643 |
| 4 | Birth length less than 3rd percentile (HP:0003561) | 5.01588785 |
| 5 | Breast hypoplasia (HP:0003187) | 4.20145560 |
| 6 | Macrocytic anemia (HP:0001972) | 3.86644826 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.73096630 |
| 8 | Oral leukoplakia (HP:0002745) | 3.65364985 |
| 9 | Progressive muscle weakness (HP:0003323) | 3.64344550 |
| 10 | Cerebral hypomyelination (HP:0006808) | 3.53838484 |
| 11 | Carpal bone hypoplasia (HP:0001498) | 3.44267976 |
| 12 | Pallor (HP:0000980) | 3.40938330 |
| 13 | Patellar aplasia (HP:0006443) | 3.32553030 |
| 14 | Rough bone trabeculation (HP:0100670) | 3.30205098 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.28989661 |
| 16 | Mitochondrial inheritance (HP:0001427) | 3.27563437 |
| 17 | Aplastic anemia (HP:0001915) | 3.20949692 |
| 18 | Increased hepatocellular lipid droplets (HP:0006565) | 3.17261181 |
| 19 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.16249952 |
| 20 | Increased CSF lactate (HP:0002490) | 3.11379700 |
| 21 | Abnormality of glycolysis (HP:0004366) | 3.01673537 |
| 22 | Increased serum pyruvate (HP:0003542) | 3.01673537 |
| 23 | Hepatocellular necrosis (HP:0001404) | 2.93252192 |
| 24 | Acute encephalopathy (HP:0006846) | 2.90768371 |
| 25 | Progressive macrocephaly (HP:0004481) | 2.90624903 |
| 26 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.88532827 |
| 27 | Chromsome breakage (HP:0040012) | 2.87994737 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.86737406 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.86737406 |
| 30 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.82561003 |
| 31 | Progressive external ophthalmoplegia (HP:0000590) | 2.82092602 |
| 32 | Increased serum lactate (HP:0002151) | 2.79694361 |
| 33 | Abnormality of the anterior horn cell (HP:0006802) | 2.79566471 |
| 34 | Degeneration of anterior horn cells (HP:0002398) | 2.79566471 |
| 35 | Absent radius (HP:0003974) | 2.77538080 |
| 36 | Absent thumb (HP:0009777) | 2.77405029 |
| 37 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.75433650 |
| 38 | Microretrognathia (HP:0000308) | 2.74697867 |
| 39 | Lipid accumulation in hepatocytes (HP:0006561) | 2.72955388 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.72590481 |
| 41 | Meckel diverticulum (HP:0002245) | 2.72176459 |
| 42 | Abnormality of the preputium (HP:0100587) | 2.68303804 |
| 43 | Exertional dyspnea (HP:0002875) | 2.62850707 |
| 44 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.62528737 |
| 45 | Abnormality of the ileum (HP:0001549) | 2.61597786 |
| 46 | Aplasia involving forearm bones (HP:0009822) | 2.59491514 |
| 47 | Absent forearm bone (HP:0003953) | 2.59491514 |
| 48 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.58499451 |
| 49 | Selective tooth agenesis (HP:0001592) | 2.52569002 |
| 50 | Horseshoe kidney (HP:0000085) | 2.51985327 |
| 51 | Hepatic necrosis (HP:0002605) | 2.48970390 |
| 52 | Type I transferrin isoform profile (HP:0003642) | 2.48793278 |
| 53 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.48467110 |
| 54 | Stenosis of the external auditory canal (HP:0000402) | 2.47391430 |
| 55 | Abnormal trabecular bone morphology (HP:0100671) | 2.46768020 |
| 56 | Premature graying of hair (HP:0002216) | 2.44589647 |
| 57 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.43358358 |
| 58 | Multiple enchondromatosis (HP:0005701) | 2.42540796 |
| 59 | Colon cancer (HP:0003003) | 2.40926294 |
| 60 | Secondary amenorrhea (HP:0000869) | 2.40047729 |
| 61 | Trismus (HP:0000211) | 2.38377402 |
| 62 | Squamous cell carcinoma (HP:0002860) | 2.36427483 |
| 63 | Triphalangeal thumb (HP:0001199) | 2.32265107 |
| 64 | Abnormal lung lobation (HP:0002101) | 2.30865597 |
| 65 | Embryonal renal neoplasm (HP:0011794) | 2.29740040 |
| 66 | Cleft eyelid (HP:0000625) | 2.29713090 |
| 67 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.29244030 |
| 68 | Premature ovarian failure (HP:0008209) | 2.29167881 |
| 69 | Abnormality of chromosome stability (HP:0003220) | 2.29066743 |
| 70 | Respiratory difficulties (HP:0002880) | 2.26385800 |
| 71 | Bone marrow hypocellularity (HP:0005528) | 2.25861316 |
| 72 | Cellular immunodeficiency (HP:0005374) | 2.25095577 |
| 73 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.24832073 |
| 74 | Renal Fanconi syndrome (HP:0001994) | 2.24336745 |
| 75 | Duplicated collecting system (HP:0000081) | 2.24099478 |
| 76 | Exercise intolerance (HP:0003546) | 2.20956339 |
| 77 | Spastic diplegia (HP:0001264) | 2.20656944 |
| 78 | Small intestinal stenosis (HP:0012848) | 2.18697522 |
| 79 | Duodenal stenosis (HP:0100867) | 2.18697522 |
| 80 | 11 pairs of ribs (HP:0000878) | 2.18063355 |
| 81 | Medulloblastoma (HP:0002885) | 2.14435100 |
| 82 | Supernumerary spleens (HP:0009799) | 2.11647164 |
| 83 | Pancytopenia (HP:0001876) | 2.10705651 |
| 84 | Respiratory failure (HP:0002878) | 2.10441404 |
| 85 | Abnormality of the umbilical cord (HP:0010881) | 2.10098901 |
| 86 | Impulsivity (HP:0100710) | 2.08142472 |
| 87 | Abnormality of methionine metabolism (HP:0010901) | 2.08114080 |
| 88 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.08047187 |
| 89 | Cerebral edema (HP:0002181) | 2.07525940 |
| 90 | Ragged-red muscle fibers (HP:0003200) | 2.05489177 |
| 91 | Abnormal number of incisors (HP:0011064) | 2.04106160 |
| 92 | Glossoptosis (HP:0000162) | 2.03043479 |
| 93 | Irregular epiphyses (HP:0010582) | 2.02846370 |
| 94 | Myelodysplasia (HP:0002863) | 2.02565712 |
| 95 | Facial cleft (HP:0002006) | 2.02228360 |
| 96 | Lactic acidosis (HP:0003128) | 1.98604615 |
| 97 | CNS hypomyelination (HP:0003429) | 1.97541967 |
| 98 | Sparse eyelashes (HP:0000653) | 1.97237897 |
| 99 | Increased nuchal translucency (HP:0010880) | 1.96869394 |
| 100 | Abnormality of reticulocytes (HP:0004312) | 1.96123778 |
| 101 | Hypoplasia of the radius (HP:0002984) | 1.95198610 |
| 102 | Poor head control (HP:0002421) | 1.94368993 |
| 103 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.94212124 |
| 104 | Microvesicular hepatic steatosis (HP:0001414) | 1.94171362 |
| 105 | Ectopic kidney (HP:0000086) | 1.93962784 |
| 106 | Neoplasm of the pancreas (HP:0002894) | 1.93823123 |
| 107 | Atresia of the external auditory canal (HP:0000413) | 1.91939620 |
| 108 | Abnormality of the renal collecting system (HP:0004742) | 1.91277583 |
| 109 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90644945 |
| 110 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.90437574 |
| 111 | Dysphonia (HP:0001618) | 1.88877569 |
| 112 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.88615745 |
| 113 | Tracheoesophageal fistula (HP:0002575) | 1.86908912 |
| 114 | Increased muscle lipid content (HP:0009058) | 1.86849777 |
| 115 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.86583744 |
| 116 | Absent epiphyses (HP:0010577) | 1.86583744 |
| 117 | Duplication of thumb phalanx (HP:0009942) | 1.86062529 |
| 118 | Single umbilical artery (HP:0001195) | 1.85899615 |
| 119 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.85899615 |
| 120 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.79549844 |
| 121 | Cafe-au-lait spot (HP:0000957) | 1.79433923 |
| 122 | Ependymoma (HP:0002888) | 1.76906144 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 1.76882994 |
| 124 | Megaloblastic anemia (HP:0001889) | 1.76523034 |
| 125 | Abnormality of the carotid arteries (HP:0005344) | 1.69785988 |
| 126 | Choanal atresia (HP:0000453) | 1.68035577 |
| 127 | Angiofibromas (HP:0010615) | 1.67542092 |
| 128 | Adenoma sebaceum (HP:0009720) | 1.67542092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.42622065 |
| 2 | WEE1 | 4.49304051 |
| 3 | EIF2AK1 | 3.68250609 |
| 4 | NME2 | 3.38944888 |
| 5 | CDC7 | 3.10546154 |
| 6 | VRK2 | 3.03857753 |
| 7 | SRPK1 | 2.97099802 |
| 8 | STK16 | 2.86467399 |
| 9 | PLK4 | 2.65269785 |
| 10 | VRK1 | 2.51933070 |
| 11 | EIF2AK3 | 2.51101643 |
| 12 | SMG1 | 2.47099943 |
| 13 | BRSK2 | 2.08495298 |
| 14 | TSSK6 | 2.04500264 |
| 15 | TESK2 | 1.97597252 |
| 16 | TTK | 1.94465407 |
| 17 | ACVR1B | 1.90691910 |
| 18 | PBK | 1.88378982 |
| 19 | PLK1 | 1.86852038 |
| 20 | NEK2 | 1.83277897 |
| 21 | MKNK1 | 1.78038955 |
| 22 | CCNB1 | 1.77624561 |
| 23 | NME1 | 1.71594702 |
| 24 | NEK1 | 1.71126705 |
| 25 | DYRK3 | 1.62959928 |
| 26 | PLK3 | 1.60708154 |
| 27 | TAF1 | 1.60195975 |
| 28 | PDK2 | 1.57840367 |
| 29 | TLK1 | 1.54654816 |
| 30 | AURKB | 1.54322828 |
| 31 | PIM2 | 1.52986630 |
| 32 | AURKA | 1.45749326 |
| 33 | CDK7 | 1.43598817 |
| 34 | MAP3K10 | 1.33014139 |
| 35 | BRSK1 | 1.29407865 |
| 36 | ICK | 1.28715217 |
| 37 | ZAK | 1.25948849 |
| 38 | MKNK2 | 1.25110232 |
| 39 | BRAF | 1.24578197 |
| 40 | ATR | 1.22248884 |
| 41 | CHEK2 | 1.17984414 |
| 42 | KDR | 1.15016464 |
| 43 | RPS6KA4 | 1.14832035 |
| 44 | EEF2K | 1.12858069 |
| 45 | MAP3K8 | 1.11049380 |
| 46 | MST4 | 1.09638746 |
| 47 | DYRK2 | 1.03860107 |
| 48 | RPS6KB2 | 1.02752499 |
| 49 | MAP3K12 | 1.01355139 |
| 50 | PASK | 0.98310996 |
| 51 | EPHA2 | 0.96463165 |
| 52 | EIF2AK2 | 0.93349734 |
| 53 | STK4 | 0.93242956 |
| 54 | LATS2 | 0.88524663 |
| 55 | TRIM28 | 0.88332125 |
| 56 | CHEK1 | 0.85695223 |
| 57 | CSNK2A1 | 0.82349984 |
| 58 | PRPF4B | 0.82024881 |
| 59 | PAK4 | 0.80850697 |
| 60 | PAK1 | 0.78365144 |
| 61 | ABL2 | 0.77629024 |
| 62 | CDK4 | 0.76996318 |
| 63 | CSNK2A2 | 0.75510507 |
| 64 | MAP3K11 | 0.73818073 |
| 65 | ARAF | 0.72861255 |
| 66 | STK10 | 0.71886356 |
| 67 | CDK19 | 0.69486209 |
| 68 | ALK | 0.68471391 |
| 69 | MST1R | 0.66790473 |
| 70 | PNCK | 0.66701650 |
| 71 | MAP3K9 | 0.66221253 |
| 72 | CDK8 | 0.65673485 |
| 73 | DAPK1 | 0.64811381 |
| 74 | LIMK1 | 0.64523549 |
| 75 | RPS6KA5 | 0.64311959 |
| 76 | TESK1 | 0.64293979 |
| 77 | PIM1 | 0.64199177 |
| 78 | CDK12 | 0.63362841 |
| 79 | LRRK2 | 0.62262280 |
| 80 | CLK1 | 0.61232647 |
| 81 | TGFBR1 | 0.61009487 |
| 82 | ERBB4 | 0.57050183 |
| 83 | AKT3 | 0.55872649 |
| 84 | CDK2 | 0.55562667 |
| 85 | PRKCI | 0.54971448 |
| 86 | ATM | 0.54848323 |
| 87 | CDK6 | 0.51490749 |
| 88 | BCR | 0.50536778 |
| 89 | BCKDK | 0.48776928 |
| 90 | CSNK1G3 | 0.48066349 |
| 91 | CDK1 | 0.46297624 |
| 92 | SCYL2 | 0.45650584 |
| 93 | YES1 | 0.43335509 |
| 94 | TAOK2 | 0.42216993 |
| 95 | BRD4 | 0.41933112 |
| 96 | IRAK3 | 0.41500652 |
| 97 | DAPK3 | 0.39541348 |
| 98 | ILK | 0.39534174 |
| 99 | BMX | 0.36451237 |
| 100 | IRAK4 | 0.34073284 |
| 101 | MAP3K5 | 0.33103007 |
| 102 | KSR2 | 0.32063467 |
| 103 | OBSCN | 0.30463626 |
| 104 | CSNK1G1 | 0.29957271 |
| 105 | FGFR1 | 0.29916393 |
| 106 | STK38L | 0.27984956 |
| 107 | MAP3K3 | 0.27659259 |
| 108 | MAP2K7 | 0.27260322 |
| 109 | TEC | 0.26719827 |
| 110 | MELK | 0.24562365 |
| 111 | STK24 | 0.21557845 |
| 112 | CDK11A | 0.20196248 |
| 113 | CSNK1E | 0.19685895 |
| 114 | AKT2 | 0.19677915 |
| 115 | MAP4K1 | 0.18223075 |
| 116 | NUAK1 | 0.17671905 |
| 117 | NLK | 0.17649501 |
| 118 | IKBKB | 0.17418098 |
| 119 | STK3 | 0.16509876 |
| 120 | BTK | 0.15289629 |
| 121 | CDK14 | 0.15069436 |
| 122 | CDK18 | 0.14904060 |
| 123 | RAF1 | 0.14863987 |
| 124 | LYN | 0.14604870 |
| 125 | CDK15 | 0.13458494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.66764108 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.49775149 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 4.49323464 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 4.09360778 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.71402101 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.38924984 |
| 7 | * Spliceosome_Homo sapiens_hsa03040 | 3.19648132 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.83574042 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.82292830 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.76761124 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.75980464 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.75232533 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 2.18988032 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.07227188 |
| 15 | Basal transcription factors_Homo sapiens_hsa03022 | 2.04834129 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.98226825 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.97372666 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.89821825 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.87997517 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.86172714 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.80336315 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.66214914 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.65656879 |
| 24 | Purine metabolism_Homo sapiens_hsa00230 | 1.58218920 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.40659944 |
| 26 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.31173386 |
| 27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.23188647 |
| 28 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.13463473 |
| 29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.12594651 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08035549 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07651693 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07558771 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04313875 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01696147 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98700640 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90493014 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89423191 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89371470 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87335787 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84683735 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82983769 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74557533 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74483482 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69165277 |
| 45 | Bladder cancer_Homo sapiens_hsa05219 | 0.68943337 |
| 46 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65088213 |
| 47 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65001905 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62571573 |
| 49 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.58608539 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57630532 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56169891 |
| 52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54761453 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53012764 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.51830241 |
| 55 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51446436 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50689434 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50155588 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49428926 |
| 59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45061681 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44283336 |
| 61 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43512926 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42660355 |
| 63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41356783 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38167872 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36882715 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36678718 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.34741883 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.31764336 |
| 69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30500139 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29769929 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28879747 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.26815486 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26163206 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.26049107 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25481543 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24807079 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.24698257 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.24583722 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.24368304 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.23636559 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23163457 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.22595830 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.22100417 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.20953201 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.20692731 |
| 86 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.19512403 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.19159144 |
| 88 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.19006157 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.18594099 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.17396292 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16741896 |
| 92 | Adherens junction_Homo sapiens_hsa04520 | 0.16613693 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.16494697 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.15127272 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.14524118 |
| 96 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.14016303 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.13747580 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.13238769 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.13010343 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.12860527 |
| 101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.12529678 |
| 102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.12424685 |
| 103 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.12421638 |
| 104 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.12160240 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.12126330 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.11524771 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.11502516 |
| 108 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.10774045 |
| 109 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.10500358 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.09559357 |
| 111 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.09367879 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.07999605 |
| 113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.07600240 |
| 114 | Measles_Homo sapiens_hsa05162 | 0.06976104 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.06772209 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.05887235 |
| 117 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.05588849 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.05281167 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.05231159 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05212914 |
| 121 | Hepatitis B_Homo sapiens_hsa05161 | 0.04779331 |

